ISN-ACT Global Trials Focus Subgroup member Maria Chiara Pelle summarizes the design and outcomes of one of the ISN-ACT Global Trials Focus’ latest trial selections. Read all the latest global trial selections from the ISN-ACT initiative here. The “trial of the month” is available in several languages. Letermovir vs Valganciclovir for Prophylaxis of Cytomegalovirus in High-risk Kidney Transplant...
Kidney International® A Prospective Controlled, Randomized Clinical Trial of Kidney Transplant Recipients Developed Personalized Tacrolimus Dosing Using Model-based Bayesian Prediction In this study, a population pharmacokinetic (PPK) model, incorporating factors such as genetics, age, and hematocrit, was developed and validated to optimize tacrolimus (Tac) dosage for kidney transplant recipients. PPK-based dosing was compared with traditional weight-based dosing....
Delegates at the first edition of the Primer Course in Glomerular Diseases in Tokyo The "Primer Course in Glomerular Diseases" covers best practices in glomerulonephritis management for trainees and early career clinicians. The ISN's first edition of the course took place in Tokyo, Japan, from October 1-2, 2023, held in partnership with the Asian Pacific Society of...
The ISN is delighted to announce the results of its latest grant application period. We are pleased to welcome participants from fifteen countries worldwide: Six new ISN Fellows who will receive training to help them establish or improve local care in their home regions. The awardees are from Fiji, Kenya, Nigeria, the Solomon Islands and...
KRACON23 delegates at the onsite ISN booth In September, the ISN supported the Kenya Renal Association and its Annual Conference (KRACON23) in Mombasa, Kenya, through its Educational Ambassador (EA) and Continuing Medical Education Programs. The theme of the event was "Multidisciplinary Approach to Kidney Care." A well-attended gathering The congress saw an impressive turnout of over 500...
To stay updated on the latest research and developments in kidney care, access the latest selection of global trials from the ISN-ACT initiative here in multiple languages. ISN-ACT Global Trials Focus Coordinator Michele Provenzano summarizes the design and outcomes of the ISN-ACT Global Trials Focus’ latest “Trial of the Month.” Balanced Crystalloid Solution Versus Saline in...
Kidney International® Models of Care to Address Disparities in Kidney Health Outcomes for First Nation People First Nations people in Australia, New Zealand, Canada, and the USA face a higher risk of kidney problems and struggle to get kidney transplants compared to non-Indigenous people. This review identifies studies that created special healthcare programs for First Nations people...
The 2023 ISN-Global Kidney Health Atlas (ISN-GKHA) is driving positive change in kidney care on a global scale, and you can play a role in this transformation! Assessing global kidney care: ISN-GKHA's comprehensive analysis for informed health policies The ISN-GKHA is a comprehensive resource offering an overview of the current readiness, capacity, and competence for kidney...
In this engaging dialogue, Augusto Cesar Santos Jr. and Peter Kotanko discuss the evolving role of artificial intelligence (AI) in medicine, particularly within kidney care. Listen here They shed light on how AI can serve as a valuable tool for healthcare providers, enabling them to predict patient outcomes, personalize treatment plans and empower patients to take...
Discover the latest addition to the ISN Academy – an exclusive curriculum on rare diseases, with a special focus on complement pathway disorders. This comprehensive course is designed to provide an in-depth understanding of the pathophysiology, diagnosis, and advanced management of complement-mediated kidney diseases. Explore the curriculum here What's included? A seven-module course covering: Comprehensive pathophysiology insights Advanced diagnosis techniques Expert-driven...
The ISN endorses high-quality events for the kidney care community. Whether your event is big or small, it may be eligible for endorsement if it addresses relevant topics in the region. Join us for enhanced visibility, scientific merit, and educational impact. Discover all the benefits of ISN-endorsed meetings and how to apply here. October 4-7 The XV...
Delegates and faculty at the 2ème Cours International de Nephrologie, Dialyse et Transplantation, and 1er Congrès de la Société Congolaise In support of an agreement between the Société Francophone Néphrologie, Dialyse et Transplantation (SFNDT) and the ISN to enhance skills in French-speaking African countries, the ISN Continuing Medical Education Program contributed to the 2ème Cours...
Anastasiia Zykova, ISN Advancing Clinical Trials Network member, summarizes the design and outcomes of a study from the ISN-ACT Global Trials Focus' most recent global trials selection. Evaluation of a simple, low-cost intervention to empower people with chronic kidney disease to reduce their dietary salt intake: OxCKD1, a multi-center randomized controlled trial. Summary In this trial, 193 adult participants...
Ronald Gobina trained through the ISN Interventional Nephrology Scholarship Program for four weeks at the South West Thames Renal and Transplantation Unit at St Helier Hospital in London, UK. Dr. Gobina recently contacted the ISN to tell us how he applied his newly acquired skills to enhance the quality of kidney care at the Regional...
Kidney International® Novel Anemia Therapies in CKD: Conclusions from a KDIGO Controversies Conference The conference, held virtually in December 2021, reviewed new evidence on diagnosing and managing anemia in chronic kidney disease (CKD). The meeting focused on a new class of agents—the hypoxia-inducible factor-prolyl hydroxylase inhibitors (HIF-PHIs). HIF-PHIs are reported to be non-inferior to conventional Erythropoiesis-Stimulating Agents...
The ISN was pleased to support the inaugural "Primer Curso Cubano de Nefrología Intervencionista" (First Cuban Course on Interventional Nephrology) in September through its Continuing Medical Education and Educational Ambassadors Programs. Find out more about ISN interventional nephrology training opportunities here. Hosted by the Cuban Society of Nephrology at the Hospital Clínico Quirúrgico Lucía Iñiguez Landín...
The ISN “Are Your Kidneys Healthy?” Quiz is now available in Finnish! This quick and informative quiz, available in 17 languages, helps individuals assess their risk of kidney disease. If you would like to contribute by translating it into another language, please contact Monica at mmoorthy@theisn.org.
The newly updated ISN iNET-CKD Network cohorts map features a new layout, revised information on cohorts, and additional data. Access the ISN iNET-CKD Network cohorts map here. The ISN iNET-CKD Network is one-of-a-kind. It tracks ongoing chronic kidney disease (CKD) cohort studies located worldwide, facilitating an exchange of insights into CKD progression and its global implications. This network's...
The complete "Online Kidney Education for Primary Care Physicians" curriculum is now available at the ISN Academy. What is it? Developed collaboratively by the ISN and the Mumbai Kidney Foundation, this curriculum equips primary care physicians with the necessary knowledge and skills to manage and care for patients with kidney-related issues. Explore the complete list of modules...
Kidney International® Repurposing Drugs for Diseases Associated With Podocyte Dysfunction Due to recent advances in understanding the molecular and cellular mechanisms underlying podocyte injury, there is potential for repurposing already approved therapeutics for treating these disorders. This mini-review explores the complexities of repurposing drugs for kidney treatment, emphasizing the importance of extensive testing, emerging technologies, early intervention,...
